Latest on Pharmaceutical Industry


United Therapeutics And MannKind Announce Closing Of License And Collaboration Agreement

United Therapeutics Corporation and MannKind Corporation today announced the closing of their pending worldwide exclusive license and collaboration agreement for the development and commercialization of Treprostinil Tech..Read More...

FDA approves Pfizer's drug for advanced breast cancer

The U.S. Food and Drug Administration said on Tuesday it approved Pfizer Inc’s drug for an advanced form of breast cancer tied to an inherited gene mutation. The drug, talazoparib, belongs to a closely watched class..Read More...



Digital Pharma East Conference

Pennsylvania Convention Center,
ExL Events


TIACA’s International Air Cargo Forum and Exhibition 2018

Metro Toronto Convention Centre,

Press Releases

OncBioMune Signs Work Order for Phase 2 Clinical Trial of ProscaVax for Late Stage Prostate Cancer

OncBioMune Pharmaceuticals Inc a clinicalstage biopharmaceutical company engaged in the development of a proprietary therapeutic cancer vaccine immunotherapy and targeted cancer therapies today announces the signing of a.. Read More...

Eiger BioPharmaceuticals Announces Positive Results in Phase 2 PREVENT Study of Avexitide Targeting GLP-1 in Post-Bariatric Hypoglycemia (PBH)

Eiger BioPharmaceuticals Inc focused on the development and commercialization of targeted therapies for rare diseases today announced positive results from the Phase 2 PREVENT study PREVENT is a multicenter placebocontro.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Messe Muenchen India Pvt. Ltd.

Messe Muenchen India Pvt. Ltd. As per the World Bank India has made a substantial effort in attempting to address environmental challenges It has endorsed rigorous environmental legislation and has created relevant institutions to monitor and enforce legislation In response to the threat of climate change the Prime Ministers Nati. Read More...
Bhupinder Singh
Chief Executive Officer